Company · CIK 0001275187 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
ANGIODYNAMICS INC · ANGO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 SForm 4 → | Jul 31, 4:45 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 23,370 | $14.72 | $344,006 | 64,745 | −26.5% | |
| Jul 22, 2026 FMForm 4 → | Jul 24, 6:10 pm EDT | Laura PiccininiSVP International | 12,553 | $13.82 | $62,273 | 81,929 | — | |
| Jul 22, 2026 FMForm 4 → | Jul 24, 6:10 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 7,365 | $13.82 | $23,093 | 88,115 | — | |
| Jul 22, 2026 FMForm 4 → | Jul 24, 6:10 pm EDT | Stephen A TrowbridgeEVP and CFO | 24,615 | $13.82 | $114,969 | 305,796 | — | |
| Jul 22, 2026 FMForm 4 → | Jul 24, 6:10 pm EDT | James C ClemmerPresident and CEO, Director | 79,086 | $13.82 | $369,381 | 862,448 | — | |
| Jul 22, 2026 FMForm 4 → | Jul 24, 6:10 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 8,796 | $13.82 | $32,201 | 108,676 | — | |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:36 pm EDT | Lawrence T WeissSVP, Chief Legal Officer | 2,267 | $14.14 | $32,055 | 91,330 | — | late |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:32 pm EDT | Stephen A TrowbridgeEVP and CFO | 12,067 | $13.93 | $168,108 | 244,562 | — | late |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:28 pm EDT | Laura PiccininiSVP International | 8,228 | $13.87 | $114,142 | 58,528 | — | late |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:21 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 3,777 | $13.88 | $52,434 | 66,126 | — | late |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:17 pm EDT | James C ClemmerPresident and CEO, Director | 45,711 | $13.78 | $630,111 | 836,818 | — | late |
| Jul 16, 2026 FForm 4 → | Jul 21, 8:10 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 3,838 | $13.92 | $53,414 | 88,459 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Jan Stern ReedDirector | 11,887 | — | — | 116,921 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Karen A LicitraDirector | 11,887 | — | — | 102,322 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Wesley JohnsonDirector | 11,887 | — | — | 155,425 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Howard W DonnellyDirector | 11,887 | — | — | 178,938 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Lorinda BurgessDirector | 11,887 | — | — | 67,144 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Eileen O'Shea AuenDirector | 11,887 | — | — | 116,605 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Michael E TarnoffDirector | 11,887 | — | — | 95,265 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Stephen A TrowbridgeEVP and CFO | 53,257 | — | — | 297,819 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Laura PiccininiSVP International | 19,860 | — | — | 78,388 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 17,966 | — | — | 84,092 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 16,081 | — | — | 104,540 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Lawrence T WeissSVP, Chief Legal Officer | 21,288 | — | — | 112,618 | — | late |
| Feb 12, 2019 FForm 4 → | Feb 14, 6:14 pm EST | Brent J. BoucherSVP and GM of Oncology | 490 | $22.90 | $11,221 | 13,543 | — | plan? |
| Jan 31, 2019 FForm 4 → | Feb 1, 4:24 pm EST | Robert Arthur SimpsonSVP/GM, Global Vascular | 981 | $21.10 | $20,699 | 16,142 | — | plan? |
| Nov 7, 2018 SForm 4 → | Nov 8, 4:06 pm EST | Michael GreinerEVP and CFO | 1,939 | $21.53 | $41,747 | 20,731 | −8.55% | plan? |
| Jul 27, 2018 FForm 4 → | Jul 30, 6:57 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 285 | $21.42 | $6,105 | 36,554 | — | plan? |
| Jul 27, 2018 FForm 4 → | Jul 30, 6:56 pm EDT | James C ClemmerPresident and CEO, Director | 1,752 | $21.42 | $37,528 | 125,708 | — | plan? |
| Jul 27, 2018 FForm 4 → | Jul 30, 6:53 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 252 | $21.42 | $5,398 | 17,508 | — | plan? |
| Jul 26, 2018 FForm 4 → | Jul 27, 8:08 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 276 | $21.88 | $6,039 | 17,760 | — | plan? |
| Jul 26, 2018 FForm 4 → | Jul 27, 8:01 pm EDT | Michael GreinerEVP and CFO | 511 | $21.88 | $11,181 | 22,670 | — | plan? |
| Jul 26, 2018 FForm 4 → | Jul 27, 7:58 pm EDT | James C ClemmerPresident and CEO, Director | 1,826 | $21.88 | $39,953 | 127,460 | — | plan? |
| Jul 26, 2018 FForm 4 → | Jul 27, 7:55 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 308 | $21.88 | $6,739 | 17,123 | — | plan? |
| Jul 22, 2018 FForm 4 → | Jul 27, 8:13 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 1,052 | $21.67 | $22,795 | 36,839 | — | plan? late |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:43 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 4,748 | — | — | 17,431 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:41 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 4,719 | — | — | 37,891 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:38 pm EDT | Michael GreinerEVP and CFO | 6,988 | — | — | 23,181 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:36 pm EDT | James C ClemmerPresident and CEO, Director | 17,469 | — | — | 129,286 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:34 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 3,539 | — | — | 18,036 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:32 pm EDT | Jan Stern ReedDirector | 6,307 | — | — | 14,599 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:29 pm EDT | Dennis S MetenyDirector | 6,307 | — | — | 80,978 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:27 pm EDT | Steve LaPorteDirector | 6,307 | — | — | 48,484 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:25 pm EDT | Wesley JohnsonDirector | 6,307 | — | — | 58,962 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:23 pm EDT | Kevin J GouldDirector | 6,307 | — | — | 55,124 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:20 pm EDT | Eileen O'Shea AuenDirector | 6,307 | — | — | 14,283 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:18 pm EDT | Howard W DonnellyDirector | 6,307 | — | — | 68,489 | — | plan? |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:15 pm EDT | Jeffrey GoldDirector | 6,307 | — | — | 73,209 | — | plan? |
| Jul 12, 2018 FMForm 4 → | Aug 22, 7:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 4,731 | $20.50 | $24,088 | 38,935 | — | plan? late |
| Jul 6, 2018 FMForm 4 → | Jul 10, 6:44 pm EDT | Jeffrey GoldDirector | 11,004 | $17.21 | $189,405 | 66,902 | — | plan? |
| Jun 22, 2018 FMForm 4 → | Jun 25, 4:20 pm EDT | Wesley JohnsonDirector | 22,319 | $16.97 | $378,844 | 52,655 | — | plan? |
| Jun 21, 2018 FMForm 4 → | Jun 25, 4:30 pm EDT | Dennis S MetenyDirector | 22,456 | $16.87 | $378,834 | 74,671 | — | plan? |
| Jun 21, 2018 FMForm 4 → | Jun 25, 4:26 pm EDT | Howard W DonnellyDirector | 9,821 | $14.46 | $142,052 | 62,182 | — | plan? |
| Jun 21, 2018 FMForm 4 → | Jun 25, 4:23 pm EDT | Jeffrey GoldDirector | 11,228 | $16.87 | $189,417 | 63,906 | — | plan? |
| May 23, 2018 FForm 4 → | May 24, 8:58 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 827 | $20.37 | $16,846 | 14,497 | — | plan? |
| Apr 24, 2018 FForm 4 → | Apr 25, 4:57 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 1,280 | $19.76 | $25,293 | 33,172 | — | plan? |
| Jan 31, 2018 FForm 4 → | Feb 2, 3:12 pm EST | Robert Arthur SimpsonSVP/GM, Global Vascular | 1,056 | $17.41 | $18,385 | 12,683 | — | plan? |
| Nov 21, 2017 FMForm 4 → | Nov 22, 1:48 pm EST | Howard W DonnellyDirector | 24,873 | $15.23 | $378,828 | 58,703 | — | plan? |
| Nov 15, 2017 SForm 4 → | Nov 17, 4:08 pm EST | Stark RichardSVP, GM - Oncology | 27,409 | $16.29 | $446,493 | 20,754 | −56.9% | plan? |
| Nov 15, 2017 MForm 4 → | Nov 17, 4:08 pm EST | Stark RichardSVP, GM - Oncology | 27,409 | $11.45 | $313,815 | 48,163 | — | plan? |
| Sep 12, 2017 FMForm 4 → | Sep 14, 3:24 pm EDT | Kevin J GouldDirector | 69,247 | $15.80 | $1,094,338 | 48,817 | — | plan? |
| Aug 6, 2017 FForm 4 → | Aug 8, 5:49 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 495 | $16.56 | $8,197 | 34,452 | — | plan? |
| Aug 6, 2017 FForm 4 → | Aug 8, 5:46 pm EDT | Stark RichardSVP, GM - Oncology | 502 | $16.56 | $8,313 | 20,754 | — | plan? |
| Jul 26, 2017 AFForm 4 → | Jul 28, 5:38 pm EDT | James C ClemmerPresident and CEO, Director | 24,050 | $16.36 | $32,033 | 111,817 | — | plan? |
| Jul 26, 2017 AFForm 4 → | Jul 28, 5:35 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 3,624 | $16.36 | $4,614 | 15,324 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:43 pm EDT | Jan Stern ReedDirector | 7,976 | — | — | 8,292 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:41 pm EDT | Dennis S MetenyDirector | 7,976 | — | — | 69,127 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:39 pm EDT | Steve LaPorteDirector | 7,976 | — | — | 42,177 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:37 pm EDT | Wesley JohnsonDirector | 7,976 | — | — | 46,974 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:33 pm EDT | Kevin J GouldDirector | 7,976 | — | — | 40,064 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:20 pm EDT | Eileen O'Shea AuenDirector | 7,976 | — | — | 7,976 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:17 pm EDT | Howard W DonnellyDirector | 7,976 | — | — | 55,576 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:12 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 3,739 | — | — | 13,739 | — | plan? |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:08 pm EDT | Michael GreinerEVP and CFO | 6,193 | — | — | 16,193 | — | plan? |
| Jul 25, 2017 FMForm 4 → | Aug 8, 5:48 pm EDT | Wesley JohnsonDirector | 26,879 | $16.41 | $440,988 | 48,095 | — | plan? late |
| Jul 25, 2017 FMForm 4 → | Aug 8, 5:44 pm EDT | Dennis S MetenyDirector | 26,879 | $16.41 | $440,988 | 70,248 | — | plan? late |
| Jul 25, 2017 AFMForm 4 → | Jul 28, 3:47 pm EDT | Jeffrey GoldDirector | 34,855 | $16.41 | $440,988 | 61,134 | — | plan? late |
| Jul 24, 2017 PForm 4 → | Jul 25, 2:33 pm EDT | Jan Stern ReedDirector | 316 | $16.00 | $5,056 | 316 | — | plan? |
| Jul 22, 2017 AFForm 4 → | Jul 28, 3:15 pm EDT | Stark RichardSVP, GM - Oncology | 4,473 | $16.97 | $13,998 | 21,256 | — | plan? late |
| Jul 22, 2017 AFForm 4 → | Jul 28, 3:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 4,539 | $16.97 | $14,151 | 34,947 | — | plan? late |
| Jul 21, 2017 PForm 4 → | Jul 21, 9:46 pm EDT | Howard W DonnellyDirector | 5,000 | $15.72 | $78,600 | 47,600 | +11.7% | plan? |
| Jul 20, 2017 PForm 4 → | Jul 21, 6:43 pm EDT | James C ClemmerPresident and CEO, Director | 25,000 | $15.67 | $391,750 | 91,683 | +37.5% | plan? |
| Jun 19, 2017 FMForm 4 → | Jun 21, 9:42 pm EDT | Howard W DonnellyDirector | 27,544 | $16.01 | $440,996 | 42,600 | — | plan? |
| May 23, 2017 FForm 4 → | May 25, 6:07 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 788 | $15.82 | $12,466 | 12,264 | — | plan? |
| Apr 24, 2017 FForm 4 → | Apr 25, 4:14 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 1,585 | $15.78 | $25,011 | 32,076 | — | plan? |
| Apr 12, 2017 SForm 4 → | Apr 14, 4:48 pm EDT | David F BurgstahlerDirector, 10% Owner | 2,350,000 | $16.00 | $37,600,000 | 381,406 | −86.0% | plan? |
| Apr 12, 2017 SForm 4 → | Apr 14, 4:40 pm EDT | Avista Capital Partners GP, LLC +310% Owner | 2,350,000 | $16.00 | $37,600,000 | 381,406 | −86.0% | plan? |
| Apr 4, 2017 FForm 4 → | Apr 10, 2:00 pm EDT | James C ClemmerPresident and CEO, Director | 4,508 | $17.06 | $76,906 | 66,683 | — | plan? late |
| Jan 13, 2017 FMForm 4 → | Jan 17, 2:34 pm EST | Steve LaPorteDirector | 28,000 | $16.84 | $471,380 | 34,201 | — | plan? |
| Nov 18, 2016 JForm 4 → | Nov 22, 4:21 pm EST | David F BurgstahlerDirector, 10% Owner | 408,706 | $15.68 | $6,408,510 | 765,590 | — | plan? |
| Nov 18, 2016 SForm 4 → | Nov 22, 4:21 pm EST | David F BurgstahlerDirector, 10% Owner | 2,091,294 | $15.68 | $32,791,490 | 1,014,058 | −67.3% | plan? |
| Nov 18, 2016 JForm 4 → | Nov 22, 4:20 pm EST | Avista Capital Partners GP, LLC +310% Owner | 408,706 | $15.68 | $6,408,510 | 765,590 | — | plan? |
| Nov 18, 2016 SForm 4 → | Nov 22, 4:20 pm EST | Avista Capital Partners GP, LLC +310% Owner | 2,091,294 | $15.68 | $32,791,490 | 1,014,058 | −67.3% | plan? |
| Aug 31, 2016 FMForm 4 → | Sep 6, 6:54 pm EDT | Dennis S MetenyDirector | 21,642 | $14.74 | $318,959 | 61,151 | — | plan? late |
| Aug 31, 2016 FMForm 4 → | Sep 6, 6:51 pm EDT | Jeffrey GoldDirector | 21,642 | $14.74 | $318,959 | 52,037 | — | plan? late |
| Aug 18, 2016 AForm 4 → | Aug 22, 6:52 pm EDT | Michael GreinerEVP and CFO | 10,000 | — | — | 10,000 | — | plan? |
| Aug 8, 2016 FForm 4 → | Aug 9, 5:25 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 497 | $15.49 | $7,699 | 30,783 | — | plan? |
| Aug 5, 2016 SForm 4 → | Aug 5, 4:42 pm EDT | David F BurgstahlerDirector, 10% Owner | 2,250,000 | $14.62 | $32,895,000 | 1,555,407 | −59.1% | plan? |
| Aug 5, 2016 SForm 4 → | Aug 5, 4:39 pm EDT | Avista Capital Partners GP, LLC +310% Owner | 2,241,000 | $14.62 | $32,763,420 | 1,555,407 | −59.0% | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:48 pm EDT | David F BurgstahlerDirector | 5,063 | — | — | 23,988 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Laura PiccininiSVP International | 28,336 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 20,052 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Stephen A TrowbridgeEVP and CFO | 57,381 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | James C ClemmerPresident and CEO, Director | 184,361 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 22,768 | — | — | 0 | — | |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Stephen A TrowbridgeEVP and CFO | 53,257 | — | — | 53,257 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Laura PiccininiSVP International | 19,860 | — | — | 19,860 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 17,966 | — | — | 17,966 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 16,081 | — | — | 16,081 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Lawrence T WeissSVP, Chief Legal Officer | 21,288 | — | — | 21,288 | — | late |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:43 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 24,622 | — | — | 9,496 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:41 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 24,469 | — | — | 9,437 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:38 pm EDT | Michael GreinerEVP and CFO | 36,235 | — | — | 13,975 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:36 pm EDT | James C ClemmerPresident and CEO, Director | 90,589 | — | — | 34,938 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:34 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 18,355 | — | — | 7,079 | — | |
| Jul 12, 2018 MForm 4 → | Aug 22, 7:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 5,737 | — | — | 0 | — | late |
| Jul 6, 2018 MForm 4 → | Jul 10, 6:44 pm EDT | Jeffrey GoldDirector | 7,000 | — | — | 0 | — | |
| Jun 22, 2018 MForm 4 → | Jun 25, 4:20 pm EDT | Wesley JohnsonDirector | 14,000 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:30 pm EDT | Dennis S MetenyDirector | 14,000 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:26 pm EDT | Howard W DonnellyDirector | 6,650 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:23 pm EDT | Jeffrey GoldDirector | 7,000 | — | — | 0 | — | |
| Nov 21, 2017 MForm 4 → | Nov 22, 1:48 pm EST | Howard W DonnellyDirector | 14,000 | — | — | 0 | — | |
| Nov 15, 2017 MForm 4 → | Nov 17, 4:08 pm EST | Stark RichardSVP, GM - Oncology | 27,409 | — | — | 0 | — | |
| Sep 12, 2017 MForm 4 → | Sep 14, 3:24 pm EDT | Kevin J GouldDirector | 39,000 | — | — | 0 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 5:38 pm EDT | James C ClemmerPresident and CEO, Director | 121,811 | — | — | 44,184 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 5:35 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 18,428 | — | — | 6,684 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:15 pm EDT | Stark RichardSVP, GM - Oncology | 20,114 | — | — | 7,296 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:12 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 20,614 | — | — | 7,477 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:08 pm EDT | Michael GreinerEVP and CFO | 34,149 | — | — | 12,387 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 20,427 | — | — | 7,409 | — | |
| Jul 25, 2017 MForm 4 → | Aug 8, 5:48 pm EDT | Wesley JohnsonDirector | 14,000 | — | — | 0 | — | late |
| Jul 25, 2017 MForm 4 → | Aug 8, 5:44 pm EDT | Dennis S MetenyDirector | 14,000 | — | — | 0 | — | late |
| Jul 25, 2017 MForm 4 → | Jul 28, 3:47 pm EDT | Jeffrey GoldDirector | 14,000 | — | — | 0 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 21, 9:42 pm EDT | Howard W DonnellyDirector | 14,000 | — | — | 0 | — | |
| Jan 13, 2017 MForm 4 → | Jan 17, 2:34 pm EST | Steve LaPorteDirector | 14,000 | — | — | 0 | — | |
| Nov 7, 2016 AForm 4 → | Nov 9, 4:58 pm EST | Jan Stern ReedDirector | 25,000 | — | — | 25,000 | — | |
| Nov 7, 2016 AForm 4 → | Nov 9, 4:56 pm EST | Eileen O'Shea AuenDirector | 25,000 | — | — | 25,000 | — | |
| Aug 31, 2016 DForm 4 → | Sep 6, 6:54 pm EDT | Dennis S MetenyDirector | 12,000 | — | — | 0 | — | late |
| Aug 31, 2016 DForm 4 → | Sep 6, 6:51 pm EDT | Jeffrey GoldDirector | 12,000 | — | — | 0 | — | late |
| Aug 18, 2016 AForm 4 → | Aug 22, 6:52 pm EDT | Michael GreinerEVP and CFO | 120,000 | — | — | 20,000 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:48 pm EDT | David F BurgstahlerDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:44 pm EDT | Kevin J GouldDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:41 pm EDT | Steve LaPorteDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:37 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 19,036 | — | — | 6,984 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:30 pm EDT | Howard W DonnellyDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:27 pm EDT | Jeffrey GoldDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:25 pm EDT | Wesley JohnsonDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:21 pm EDT | Dennis S MetenyDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:18 pm EDT | James C ClemmerPresident and CEO, Director | 74,642 | — | — | 74,642 | — | |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:16 pm EDT | Howard W DonnellyDirector | 12,000 | — | — | 0 | — | |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:14 pm EDT | Wesley JohnsonDirector | 12,000 | — | — | 0 | — | |
| Jul 13, 2016 MForm 4 → | Jul 15, 7:25 pm EDT | Steve LaPorteDirector | 12,000 | — | — | 0 | — | |
| Jul 11, 2016 MForm 4 → | Aug 18, 9:15 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 7,151 | — | — | 0 | — | late |
| Apr 4, 2016 AForm 4 → | Apr 5, 4:06 pm EDT | James C ClemmerPresident and CEO, Director | 450,000 | — | — | 250,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 4:39 pm EDT | Dennis S MetenyDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 2:05 pm EDT | Wesley JohnsonDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 1:58 pm EDT | Jeffrey GoldDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 9:48 pm EDT | Charles R GreinerVP - Global Franchise | 14,100 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 9:47 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 5,800 | — | — | 0 | — | |
| Jul 22, 2015 AMForm 4 → | Aug 6, 1:54 pm EDT | Steve LaPorteDirector | 12,022 | — | — | 0 | — | late |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:35 pm EDT | Jeffrey GoldDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Kevin J GouldDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Wesley JohnsonDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:33 pm EDT | Charles R GreinerVP - Global Franchise | 19,654 | — | — | 5,501 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:32 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 20,495 | — | — | 5,737 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:31 pm EDT | John SotoEVP and CCO | 25,854 | — | — | 7,237 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:30 pm EDT | Stark RichardSVP, GM - Oncology | 20,420 | — | — | 5,716 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Mark T FrostEVP and CFO | 28,431 | — | — | 7,958 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Joseph DevivoPresident and CEO, Director | 133,665 | — | — | 37,414 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:27 pm EDT | Dennis S MetenyDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | David F BurgstahlerDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | Howard W DonnellyDirector | 6,022 | — | — | 6,022 | — | |
| Jul 16, 2015 MForm 4 → | Jul 17, 7:02 pm EDT | Howard W DonnellyDirector | 6,000 | — | — | 0 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 5:47 pm EDT | Wesley JohnsonDirector | 4,649 | — | — | 0 | — | |
| Feb 13, 2015 MForm 4 → | Feb 19, 4:20 pm EST | Stark RichardSVP, GM - Oncology | 18,100 | — | — | 0 | — | late |